SECTORAL ASSET MANAGEMENT INC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$5,263,860
-10.7%
1,253,300
+27.8%
1.01%
-11.2%
Q4 2022$5,891,603
+4.5%
980,300
+1.2%
1.14%
+2.7%
Q3 2022$5,636,000
+7951.4%
968,300
+2903.3%
1.11%
+15757.1%
Q3 2018$70,00032,2410.01%
Other shareholders
CTI BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,800,358$21,825,00010.02%
CAXTON CORP 2,239,300$5,553,0004.54%
Altium Capital Management LP 2,185,000$5,419,0001.49%
SILVERARC CAPITAL MANAGEMENT, LLC 1,483,829$3,680,0001.49%
Ghost Tree Capital, LLC 1,200,000$2,976,0001.07%
Lion Point Capital, LP 1,223,595$3,034,0000.81%
BVF INC/IL 8,929,690$22,146,0000.80%
NEA Management Company, LLC 7,140,450$17,708,0000.36%
Knott David M Jr 221,079$548,0000.19%
Lakeside Advisors, INC. 97,780$242,0000.18%
View complete list of CTI BIOPHARMA CORP shareholders